Trials / Completed
CompletedNCT04918290
Tegaderm Vs. Transpore for Eye Protection During Anesthesia
A Randomized Controlled Trial of Tegaderm Vs. Transpore for Eye Protection During Anesthesia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 165 (actual)
- Sponsor
- Tufts Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the rate of eyelid erythema after anesthesia with the use of TegadermTM vs. the Transpore®. Our null hypothesis is that the rate of erythema will be similar between the two groups given there is no evidence currently to suggest otherwise
Detailed description
At Tufts Medical Center, a variety of adhesive tapes are used to shut the eyes during anesthesia, including 3MTM TegadermTM and the Sharn Anesthesia Transpore®, with no preference for one or the other. While all of these products decrease the risk of corneal abrasion, none of these products have been shown to be superior to the others in terms of eyelid irritation. According to Sharn Anesthesia, "The \[Transpore®\] adhesive is light enough to reduce damage to the outer eye" (3). However, there is no scientific evidence to support this claim. All the investigators know is that the Transpore is coated with a medical grade, pressure-sensitive acrylic adhesive and that there are no phthalates, it is latex free and silicone free.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tegaderm Eye Tape | Eye tape to protect the eye from corneal abrasions during surgery. |
| DEVICE | Transpore Eye Tape | Eye tape to protect the eye from corneal abrasions during surgery. |
Timeline
- Start date
- 2021-06-11
- Primary completion
- 2024-04-17
- Completion
- 2024-05-15
- First posted
- 2021-06-08
- Last updated
- 2024-10-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04918290. Inclusion in this directory is not an endorsement.